Care of inflammatory bowel disease patients in remission

被引:19
作者
Subramanian, Charumathi Raghu [1 ]
Triadafilopoulos, George [2 ]
机构
[1] Guthrie Clin, Internal Med, Sayre, PA 18840 USA
[2] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
关键词
inflammatory bowel disease; remission; long-term care; PRIMARY SCLEROSING CHOLANGITIS; ACTIVE ULCERATIVE-COLITIS; NONMELANOMA SKIN-CANCER; POPULATION-BASED COHORT; BONE-MINERAL DENSITY; HEPATITIS-B-VIRUS; QUALITY-OF-LIFE; CROHNS-DISEASE; INCREASED RISK; VENOUS THROMBOEMBOLISM;
D O I
10.1093/gastro/gow032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease (IBD) comprises two distinct conditions: ulcerative colitis and Crohn's disease, both of which are chronic, relapsing disorders carrying significant morbidity, mortality and healthcare costs. With growing attention to coordinated healthcare for patients with chronic systemic diseases, this review focuses on the care of IBD patients in remission, their concerns, quality of life, follow-up, the role of primary care physicians and the IBD-specific aspects of long-term care. We did an extensive PubMed search for articles pertaining to IBD patients in remission and, along with the authors' experience, formulated a comprehensive review. The difficulties faced by IBD patients in remission include but are not limited to education and employment concerns, psychosocial issues, problems related to health insurance, nutrition, fertility and infections. This review also addresses newer treatment modalities, the debatable effects of smoking on IBD and the importance of vaccination. IBD in remission can be a challenge due to its multifaceted nature; however, with a coordinated approach by gastroenterologists and other involved practitioners, several of these issues can be addressed.
引用
收藏
页码:261 / 271
页数:11
相关论文
共 131 条
[1]  
Abdallah J, 2014, GASTROENTEROLOGY, V146, pS170
[2]  
Adriani A, 2014, PANMINERVA MED, V56, P145
[3]   Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review [J].
Agarwal, Nikhil ;
Ollington, Kevin ;
Kaneshiro, Marc ;
Frenck, Robert ;
Melmed, Gil Y. .
VACCINE, 2012, 30 (08) :1413-1424
[4]  
Andersen NN, 2013, 8 C ECCO VIENN AUSTR
[5]  
[Anonymous], FRONT MED
[6]   Biological therapy for ulcerative colitis [J].
Arora, Zubin ;
Shen, Bo .
GASTROENTEROLOGY REPORT, 2015, 3 (02) :103-109
[7]   Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines [J].
Atreja, Ashish ;
Aggarwal, Ashish ;
Licata, Angelo A. ;
Lashner, Bret A. .
SCIENTIFIC WORLD JOURNAL, 2012,
[8]   Cognitive function in people with chronic illness: Inflammatory bowel disease and Irritable Bowel Syndrome [J].
Attree, EA ;
Dancey, CP ;
Keeling, D ;
Wilson, C .
APPLIED NEUROPSYCHOLOGY, 2003, 10 (02) :96-104
[9]   Does preoperative stoma marking and education by the enterostomal therapist affect outcome? [J].
Bass, EM ;
DelPino, A ;
Tan, A ;
Pearl, RK ;
Orsay, CP ;
Abcarian, H .
DISEASES OF THE COLON & RECTUM, 1997, 40 (04) :440-442
[10]  
Bastida G, 2011, WORLD J GASTROENTERO, V17, P2740, DOI [10.3748/wjg.v17.i22.2734, 10.3748/wjg.v17.i22.2740]